Mieyal Paul A 4
4 · Nile Therapeutics, Inc. · Filed May 12, 2011
Insider Transaction Report
Form 4
Mieyal Paul A
Director
Transactions
- Award
Stock Option (Right to Buy)
2011-05-10+80,000→ 80,000 totalExercise: $0.73From: 2012-05-10Exp: 2021-05-10→ Common Stock (80,000 underlying)
Holdings
- 80,000
Stock Option (Right to Buy)
Exercise: $0.37From: 2011-07-26Exp: 2020-07-26→ Common Stock (80,000 underlying)
Footnotes (1)
- [F1]This option has been assigned to Wexford Capital LP.